Orthofix International NV (NASDAQ:OFIX) Chief Executive Officer could not fail to point out that2013 was a transitional and challenging year for the company as it grappled with several headwinds behind the scene,while presenting fourth quarter and full year result for the period ending December 31, 2013. The year saw the diversified medical device company implement a number of changes in its various business divisions, aimed at reviving the company’s growth metrics. Orthofix International NV (NASDAQ:OFIX) shares after opening at $26.69 moved to $30.55 on last trade day and at the end of the day closed at $30.38. Company price to sales ratio in past twelve months was calculated as 1.32 and price to cash ratio as 17.52. Orthofix International NV (NASDAQ:OFIX) showed a positive weekly performance of 21.28%.
Shares of CONN’S (NASDAQ:CONN) were the recipient of some unusual options trading activity on Tuesday. Traders acquired 8,955 put options on the stock, StockRatingsNetwork reports. This is an increase of approximately 962% compared to the average daily volume of 843 put options.CONN’S, Inc. (NASDAQ:CONN) shares advanced 13.04% in last trading session and ended the day on $39.02. CONN return on equity ratio is recorded as 16.10% and its return on assets is 8.20%. CONN’S, Inc. (NASDAQ:CONN) yearly performance is 11.33%.
The Inovio Pharmaceuticals Inc (NYSEMKT:INO) on Mar. 17 reported financial results for the fourth quarter and year ended Dec. 31, 2013. Total revenue was $1.7 million and $13.5 million for the quarter and year ended Dec. 31, 2013, versus $1.1 million and $4.1 million for the same periods in 2012. The net loss attributable to common stockholders for the quarter and year ended Dec. 31, 2013, was $15.5 million, or $0.07 per share, and $66.0 million, or $0.36 per share, as compared with a net loss attributable to common stockholders of $659,000, or $0.00 per share, and $19.7 million, or $0.14 per share, for the quarter and year ended Dec. 31, 2012. Inovio Pharmaceuticals Inc (NYSEMKT:INO) shares moved up 12.69% in last trading session and was closed at $3.64, while trading in range of $3.07-$3.64. Inovio Pharmaceuticals Inc (NYSEMKT:INO) year to date performance is 25.52%.
On Jan. 31, 2014 Accelerate Diagnostics Inc (NASDAQ:AXDX) , an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced that it has launched a new investor relations portal on its website and will be using this portal to update investors on meaningful events and information going forward. The investor portal of the website can be accessed athttp://ir.axdx.com/ .Accelerate Diagnostics Inc (NASDAQ:AXDX) weekly performance is 9.23%. On last trading day company shares ended up $19.77. Accelerate Diagnostics Inc (NASDAQ:AXDX) distance from 50-day simple moving average is 33.18%.
Leave a Reply